Skip to main content
. Author manuscript; available in PMC: 2011 Jul 28.
Published in final edited form as: Antivir Ther. 2011;16(4):527–534. doi: 10.3851/IMP1780

Table 2.

EFV median (IQR) plasma concentration in mg/L on and after antitubercular therapy with mean post-dose sampling times.

On antitubercular therapy After antitubercular therapy p value
EFV 800/600 n=38 2.9 (1.8, 5.6) 2.1 (1.4, 3.0) 0.0003*
Proportion sub- therapeutic n (%) 1 (3%) 5 (13%) 0.089**
Mean post-dose sampling time: hours (+/− SD ) 14.0 (1.5) 14.3 (1.7) 0.628#
EFV 600/600 n=34 2.4 (1.2, 5.1) 2.2 (1.4, 3.7) 0.669*
Proportion sub- therapeutic n (%) 4 (12%) 3 (9%) 0.690**
Mean post-dose sampling time: hours (+/− SD ) 13.8 (1.7) 13.8 (1.8) 0.208#

Efavirenz therapeutic range: 1.0 –4.0 mg/L

*

Wilcoxon signrank test

**

Chi-squared test

#

t-test.